Models of both non-receptor tyrosine kinase- (NRTKs) and receptor tyrosine kinase-mediated signaling pathways in tumor progression and drug resistance
Proposed model for models of both non-receptor tyrosine kinase- (NRTKs) and receptor tyrosine kinase-mediated signaling pathways in tumor progression and drug resistance. (A) NRTK-mediated signaling pathways to tumor progression and drug resistance. NRTK Fyn stimulates Stat3, CD133 signaling to PI3K/AKT/mTOR, PI3K/PDK-1, PI3K/AKT/MDM2, and Grb2/Grb7/RAS/RAF/MEK/ERK pathways in melanoma by the phosphorylation of tyrosine kinase Tyr828 and Tyr852 residues located on the cytoplasmic C-terminal domain of the CD133 protein to recruit both p85 and Grb2 proteins, respectively. P85 serves to mediate Fyn-stimulated CD133 signal to PI3K to enhance the activation of several pathways including PI3K/PDK-1/AKT/mTOR/S6K and/or PI3K/AKT/mTOR/S6K; PI3K/PDK-1/AKT/4E-BP1 and/or PI3K/AKT/4E-BP1; PI3K/PDK-1/AKT/MDM2 and/or PI3K/AKT/MDM2; PI3K/PDK-1/AKT/MKP-1 and/or PI3K/1/AKT/MKP-1. Meanwhile, Grb2serves to mediate Fyn-stimulated CD133 signal to enhance the activation of NRAS/BRAF/MEK/ERK pathway. Finally, the biological consequences of Fyn-stimulated signal to CD133 in melanoma include the enhancement of protein synthesis, cell cycle progression, cell growth, survival, and drug resistance. (B) RTK-mediated signaling pathways to tumor progression and drug resistance. By binding RTKs to their corresponding receptors, tyrosine kinases (TKs) bind ligands to initiate the signaling pathway via intermediate molecule, insulin receptor substrate (IRS). Then, the activated PI3K becomes able to phosphorylate the phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate (PIP3), a process that is reversed by PTEN. Meanwhile, at the cell membrane, proteins with pleckstrin homology domains are then phosphorylated via PIP3 (phosphoinositide-dependent protein kinase-1 (PDK1) and AKT). Also, PDK1 can phosphorylate critical residues on AKT. The tumor suppressor complex of TSC1/TSC2 normally inhibits mTOR activation via the brain-enriched Ras homologue (Rheb). Activated AKT prevents this inhibition and leads to activation of the mTOR/Raptor complex 1 (mTORC1). This complex can be inhibited by rapamycin and its analogues. Consequently, mTORC1 leads to the activation of downstream proteins involved in the initiation of protein synthesis, leading to cell growth. Also, activation of RTKs able to initiate MAPK pathway signaling, leading to tumor progression, proliferation, and drug resistance. Activation of the MAPK pathway may also enhance PI3K signaling. MEK, MAPK/ERK kinase
Publication
CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance (2024) Naji Kharouf, et al. Cells. 2024 Feb;13(3). Figure: F8.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | CD133 | CD133 | ncbigene_synonym | PROM1 | 8842 |
| Homo sapiens | Primates | mTORC2 | MTORC2 | famplex_relations | MAPKAP1 | 79109 |
| Homo sapiens | Primates | mTORC2 | MTORC2 | famplex_relations | MTOR | 2475 |
| Homo sapiens | Primates | mTORC2 | MTORC2 | famplex_relations | RICTOR | 253260 |
| Homo sapiens | Primates | mTORC2 | MTORC2 | famplex_relations | MLST8 | 64223 |
| Homo sapiens | Primates | PI(4,5)P2 | PI4 | ncbigene_synonym | SERPINA4 | 5267 |
| Homo sapiens | Primates | Deptor | DEPTOR | ncbigene_symbol | DEPTOR | 64798 |
| Homo sapiens | Primates | Fyn | FYN | ncbigene_symbol | FYN | 2534 |
| Homo sapiens | Primates | PS5) | PS5 | ncbigene_synonym | TAS2R67P | 448991 |
| Homo sapiens | Primates | Grb2 | GRB2 | ncbigene_symbol | GRB2 | 2885 |
| Homo sapiens | Primates | Grb7 | GRB7 | ncbigene_symbol | GRB7 | 2886 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | P85 | P85 | ncbigene_synonym | ARHGEF7 | 8874 |
| Homo sapiens | Primates | P85 | P85 | ncbigene_synonym | CBFA2T2 | 9139 |
| Homo sapiens | Primates | P85 | P85 | ncbigene_synonym | PPP1R13B | 23368 |
| Homo sapiens | Primates | P85 | P85 | ncbigene_synonym | PPP1R12C | 54776 |
| Homo sapiens | Primates | (NRAS) | NRAS | ncbigene_symbol | NRAS | 4893 |
| Homo sapiens | Primates | P110 | P110 | ncbigene_synonym | CUX1 | 1523 |
| Homo sapiens | Primates | P110 | P110 | ncbigene_synonym | SART3 | 9733 |
| Homo sapiens | Primates | PTEN | PTEN | ncbigene_symbol | PTEN | 5728 |
| Homo sapiens | Primates | (Stat3 | STAT3 | ncbigene_symbol | STAT3 | 6774 |
| Homo sapiens | Primates | (Stat | STAT | ncbigene_synonym | SOAT1 | 6646 |
| Homo sapiens | Primates | (Stat | STAT | famplex_relations | STAT1 | 6772 |
| Homo sapiens | Primates | (Stat | STAT | famplex_relations | STAT2 | 6773 |
| Homo sapiens | Primates | (Stat | STAT | famplex_relations | STAT4 | 6775 |
| Homo sapiens | Primates | (Stat | STAT | famplex_relations | STAT6 | 6778 |
| Homo sapiens | Primates | (Stat | STAT | famplex_relations | STAT5A | 6776 |
| Homo sapiens | Primates | (Stat | STAT | famplex_relations | STAT5B | 6777 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | BRAF | BRAF | ncbigene_symbol | BRAF | 673 |
| Homo sapiens | Primates | mTORC1 | MTORC1 | famplex_relations | RPTOR | 57521 |
| Homo sapiens | Primates | FKBP38 | FKBP38 | ncbigene_synonym | FKBP8 | 23770 |
| Homo sapiens | Primates | MDM2 | MDM2 | ncbigene_symbol | MDM2 | 4193 |
| Homo sapiens | Primates | (MKP-1) | MKP1 | ncbigene_synonym | DUSP1 | 1843 |
| Homo sapiens | Primates | MEK | MEK | ncbigene_synonym | MAP2K7 | 5609 |
| Homo sapiens | Primates | MEK | MEK | famplex_relations | MAP2K1 | 5604 |
| Homo sapiens | Primates | MEK | MEK | famplex_relations | MAP2K2 | 5605 |
| Homo sapiens | Primates | PRAS40 | PRAS40 | ncbigene_synonym | AKT1S1 | 84335 |
| Homo sapiens | Primates | p38 | P38 | ncbigene_synonym | CRK | 1398 |
| Homo sapiens | Primates | p38 | P38 | ncbigene_synonym | MAPK14 | 1432 |
| Homo sapiens | Primates | p38 | P38 | ncbigene_synonym | MAPK1 | 5594 |
| Homo sapiens | Primates | p38 | P38 | ncbigene_synonym | AIMP2 | 7965 |
| Homo sapiens | Primates | p38 | P38 | ncbigene_synonym | GRAP2 | 9402 |
| Homo sapiens | Primates | p38 | P38 | ncbigene_synonym | AHSA1 | 10598 |
| Homo sapiens | Primates | p38 | P38 | ncbigene_synonym | POLDIP2 | 26073 |
| Homo sapiens | Primates | p38 | P38 | famplex_relations | MAPK11 | 5600 |
| Homo sapiens | Primates | p38 | P38 | famplex_relations | MAPK12 | 6300 |
| Homo sapiens | Primates | p38 | P38 | famplex_relations | MAPK13 | 5603 |
| Homo sapiens | Primates | P53 | P53 | ncbigene_synonym | TP53 | 7157 |
| Homo sapiens | Primates | P53 | P53 | famplex_relations | TP63 | 8626 |
| Homo sapiens | Primates | P53 | P53 | famplex_relations | TP73 | 7161 |
| Homo sapiens | Primates | ERK | ERK | ncbigene_synonym | EPHB2 | 2048 |
| Homo sapiens | Primates | ERK | ERK | famplex_relations | MAPK3 | 5595 |
| Homo sapiens | Primates | 4E-BP1 | 4E-BP1 | ncbigene_synonym | EIF4EBP1 | 1978 |
| Homo sapiens | Primates | S6K | S6K | ncbigene_synonym | RPS6KB1 | 6198 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| MEK | MEK | butan-2-one | chebi:28398 | |
| MEK | MEK | butan-2-one | chebi:28398 | |
| Raptor | Raptor | rac-ammonium 5-(methoxymethyl)-2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]pyridine-3-carboxylate | chebi:133232 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|